Glycorex Transplantation AB Share Price
Equities
GTAB B
SE0000524530
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.912 SEK | -14.77% | -0.87% | -31.17% |
Sales 2021 | 29.01M 2.65M 212M | Sales 2022 | 37.39M 3.42M 274M | Capitalization | 303M 27.68M 2.22B |
---|---|---|---|---|---|
Net income 2021 | -12M -1.1M -87.79M | Net income 2022 | -8M -731K -58.52M | EV / Sales 2021 | 22.5 x |
Net cash position 2021 | 33.08M 3.02M 242M | Net cash position 2022 | 23.52M 2.15M 172M | EV / Sales 2022 | 7.47 x |
P/E ratio 2021 |
-56.1
x | P/E ratio 2022 |
-35.3
x | Employees | 23 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 95.58% |
1 day | -14.77% | ||
1 week | -0.87% | ||
Current month | +7.29% | ||
1 month | +4.35% | ||
3 months | -30.91% | ||
6 months | -22.71% | ||
Current year | -31.17% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Laven
CEO | Chief Executive Officer | 51 | 31/12/21 |
Founder | 71 | 31/12/95 | |
Sales & Marketing | - | 31/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 31/12/95 | |
Nils Siegbahn
CHM | Chairman | 71 | 31/12/99 |
Clas Runnberg
BRD | Director/Board Member | 72 | 31/12/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.912 | -14.77% | 21,435 |
25/04/24 | 1.07 | 0.00% | 3,091 |
24/04/24 | 1.07 | +6.47% | 16,642 |
23/04/24 | 1.005 | +12.92% | 4,728 |
22/04/24 | 0.89 | -3.26% | 22,005 |
End-of-day quote NORDIC GROWTH MARKET, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-31.17% | 6.14M | |
+11.84% | 27.79B | |
-32.98% | 2.98B | |
-15.97% | 2.52B | |
+11.90% | 2.34B | |
-1.11% | 1.91B | |
-13.37% | 1.83B | |
-7.78% | 1.39B | |
-0.38% | 1.27B | |
+13.51% | 1.12B |
- Stock Market
- Equities
- GTAB B Stock